Composite lymphoma associating diffuse large B-cell lymphoma with classical Hodgkin lymphoma [0.03%]
弥漫大B细胞淋巴瘤与经典霍奇金淋巴瘤相关联的复合淋巴瘤
Maïlis Lauwers,Valéry Daubie,Hussein Farhat et al.
Maïlis Lauwers et al.
The value of leukapheresis for treatment of priapism as presenting feature of chronic myeloid leukemia-Case report and review of literature [0.03%]
白细胞单采在治疗慢性髓系白血病所致异常勃起中的价值 --病例报道及文献复习
Marleen G A M van der Velde,Sanne M B Tiellemans,Heleen de Lil et al.
Marleen G A M van der Velde et al.
Priapism is a rare presenting feature of chronic myeloid leukemia (CML) in male patients. Treatment aims to relieve symptoms and to prevent erectile dysfunction. Several treatment modalities exist, however no standard treatment is recommend...
A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families [0.03%]
生殖系外显子分析揭示了多发性骨髓瘤患者及其家族中POT1基因的有害变异
Marja Hakkarainen,Jessica R Koski,Caroline A Heckman et al.
Marja Hakkarainen et al.
Observations of inherited susceptibility to multiple myeloma have led to active research in defining predisposing genes to the disease. Here, we analysed 128 plasma cell dyscrasia patients' germline whole-exome sequencing data. Rare dominan...
Monkeypox virus: A new etiology for reactive lymphocytes in peripheral blood [0.03%]
猴痘病毒:外周血反应性淋巴细胞的一种新病因
Jared Neeley,Sarah Glogowski,Weina Chen
Jared Neeley
Aberrant expression of cytokeratin in plasma cell neoplasms: A pitfall for diagnostic errors [0.03%]
浆细胞肿瘤中细胞角蛋白的异常表达:诊断错误的一个陷阱
Michelle Huang,Ali Sakhdari
Michelle Huang
Chauncey R Syposs,Andrew G Evans,John M Bennett et al.
Chauncey R Syposs et al.
Bortezomib-based therapy is effective and well tolerated in frontline and multiply pre-treated Waldenström macroglobulinaemia including BTKi failures: A real-world analysis [0.03%]
基于硼替佐米的疗法对一线和多次预治疗的Waldenström巨球蛋白血症(包括BTKi失败)有效且耐受性良好:真实世界分析
Jahanzaib Khwaja,Encarl Uppal,Robert Baker et al.
Jahanzaib Khwaja et al.
Waldenström macroglobulinemia (WM) is a rare, incurable low grade lymphoma following a relapsing trajectory. Management strategies have evolved with the introduction of targeted therapy including new classes of Bruton tyrosine kinase inhib...
Postallograft aleukemic mast cell leukemia, with macrophagic activation syndrome [0.03%]
邮递员白血病样类白血病反应伴巨噬细胞活化综合征
Salwa Hamdash,Corentin Deckers,Virginie Chapelle et al.
Salwa Hamdash et al.
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment [0.03%]
既往接受过抗B细胞成熟抗原治疗的多发性骨髓瘤患者的塞利尼索联合方案治疗
Muhamed Baljevic,Cristina Gasparetto,Gary J Schiller et al.
Muhamed Baljevic et al.
There is a lack of consensus on therapy sequencing in previously treated multiple myeloma, particularly after anti-B-cell maturation antigen (BCMA) therapy. Earlier reports on selinexor (X) regimens demonstrated considerable efficacy in ear...
Inflammatory biomarkers after an exercise intervention in childhood acute lymphoblastic leukemia survivors [0.03%]
儿童急性淋巴细胞白血病幸存者运动干预后的炎症生物标志物
Tuomas Lähteenmäki Taalas,Liisa Järvelä,Harri Niinikoski et al.
Tuomas Lähteenmäki Taalas et al.
Cancer survivors show increased risk for non-communicable diseases and chronic low-grade inflammation characterizes the development of such diseases. We investigated inflammatory plasma protein profiles of survivors of childhood acute lymph...